Draper Asset Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Draper Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $4,605 - $6,748	-58 Reduced 2.12%	2,672 $213,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $155,901 - $198,097	-1,804 Reduced 39.79%	2,730 $287,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $235,065 - $285,985	-2,385 Reduced 34.47%	4,534 $489,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $139,243 - $167,210	1,515 Added 28.03%	6,919 $758,000
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $107,455 - $119,516	1,246 Added 29.97%	5,404 $506,000
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $101,567 - $135,008	1,414 Added 51.53%	4,158 $383,000
Q4 2020 Mar 03, 2021	BUY	$67.0 - $84.39 $183,848 - $231,566	2,744 New	2,744 $201,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Draper Asset Management, LLC with notifications on news.